Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Share Option Plan Awards

9 Jul 2020 07:00

RNS Number : 4617S
First Derivatives PLC
09 July 2020
 

9 July 2020

 

First Derivatives plc

("FD" or the "Group")

 

Share Option Plan awards

 

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 8 July 2020 Seamus Keating, CEO, was granted options over 250,000 ordinary shares of 0.5p each ("Ordinary shares") and Graham Ferguson, CFO, was granted options over 75,000 Ordinary shares under the Group's Share Option Plan.

 

In each case, the option exercise price is 2,595p and the options will vest after four years on the achievement of challenging total shareholder return (TSR) and earnings per share (EPS) growth targets. Both TSR and EPS targets are independent of each other and are weighted 50:50 for any award vesting.

 

For the TSR portion, 50% will vest for threshold performance, which is defined as 50% TSR over the four-year performance period. This translates to a CAGR of nearly 11%. Vesting then increases on a straight-line basis to full vesting for TSR of 100% (i.e., doubling of value over the four-year performance period, or a CAGR of nearly 19%).

 

For the EPS growth portion, 50% will vest for threshold performance, which is defined as 75% EPS growth over the four-year performance period, or a CAGR of 15%. Vesting will increase on a straight-line basis to full vesting for EPS growth of 100%.

 

The option grants are in line with the Group's remuneration policy and are subject to typical holding, malus and clawback provisions.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

 

Name

 

 

 Seamus Keating

2.

Reason for the notification

a)

Position / status

 Chief Executive Officer

 

b)

Initial notification / amendment

 Initial Notification

3.

Details of the Issuer

a)

Name

First Derivatives plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.005

 ISIN: GB0031477770 

b)

Nature of the transaction

Award of share options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

250,000

d)

Aggregated information

 - Aggregated volume

 - Price

N/a - single transaction

e)

Date of the transaction

8 July 2020

f)

Place of the transaction

Outside a trading venue

 

 

2.

Details of PDMR / person closely associated with them ("PCA")

a)

 

Name

 

 

 Graham Ferguson

2.

Reason for the notification

a)

Position / status

 Chief Financial Officer

 

b)

Initial notification / amendment

 Initial Notification

3.

Details of the Issuer

a)

Name

First Derivatives plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.005

 ISIN: GB0031477770 

b)

Nature of the transaction

Award of share options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

75,000

d)

Aggregated information

 - Aggregated volume

 - Price

N/a - single transaction

e)

Date of the transaction

8 July 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

Enquiries

For further information please contact:

First Derivatives plc

Seamus Keating, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0) 20 7597 5970

 

 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

+353 (0)1 667 0420

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

 

+44 (0) 20 3727 1000

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUWSWRROUBRAR
Date   Source Headline
1st Sep 20091:24 pmRNSExercise of Options
3rd Aug 20094:40 pmRNSDirector/PDMR Shareholding
22nd Jul 20092:42 pmRNSDirector/PDMR Shareholding
23rd Jun 20095:00 pmRNSPassing of AGM Resolutions
23rd Jun 20097:00 amRNSAGM Statement
20th May 200912:50 pmRNSDividend Declaration
20th May 20097:00 amRNSDirectorate Change
20th May 20097:00 amRNSFinal Results
24th Apr 20094:45 pmRNSDirector Declaration
1st Apr 20097:00 amRNSAcquisition
31st Mar 20093:12 pmRNSTotal Voting Rights
31st Mar 20097:00 amRNSIEX Notice
25th Mar 20092:47 pmRNSIssue of Equity
30th Jan 20094:20 pmRNSTotal Voting Rights
29th Jan 200910:07 amRNSNew Investment - Replacement
29th Jan 20099:00 amRNSFinancial Support from Invest NI
26th Jan 20097:00 amRNSOEM License Agreement
23rd Jan 20093:45 pmRNSDirector/PDMR Shareholding
16th Jan 20097:00 amRNSDirectorate Change
9th Jan 20094:11 pmRNSExercise of Options
23rd Oct 20087:30 amRNSNon Regulatory Announcement
9th Oct 20087:00 amRNSInterim Results
30th Sep 20082:23 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSIssue of Equity
15th Sep 20087:00 amRNSAcquisition
28th Aug 20083:02 pmRNSAnnual Report and Accounts
27th Aug 20087:00 amRNSDirectorate Change
13th Aug 20087:00 amRNSIEX Notice
7th Aug 20084:47 pmRNSIssue of Equity
9th Jul 20087:00 amRNSRe Contract
17th Jun 200812:40 pmRNSAGM Statement
14th May 20087:00 amRNSDirectorate Change
14th May 20087:00 amRNSFinal Results
7th May 20084:22 pmRNSNotice of Results
30th Apr 20081:39 pmRNSTotal Voting Rights
29th Feb 20082:41 pmRNSIssue of Equity
28th Feb 20087:00 amRNSTrading Statement
1st Feb 20084:17 pmRNSResult of EGM
30th Nov 200711:33 amRNSTotal Voting Rights
21st Nov 20075:01 pmRNSDirector/PDMR Shareholding
14th Nov 20071:17 pmRNSIssue of Equity
9th Nov 20074:45 pmRNSDirector/PDMR Shareholding
9th Nov 20074:42 pmRNSDirector/PDMR Shareholding
1st Nov 200710:33 amRNSTotal Voting Rights
4th Oct 20075:27 pmRNSInterim Results - Replacement
4th Oct 20077:01 amRNSInterim Results
28th Sep 20073:01 pmRNSChange of Adviser
23rd Aug 20077:00 amRNSTrading Statement
23rd Aug 20077:00 amRNSTrading Statement
17th Aug 20075:01 pmRNSWebsite Information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.